Wake Up! Newsletter
Research in the News (select journal)
Within most people′s lifetimes, the developments in the biotechnology sector will allow us to live increasingly long and healthy lives, as well as provide us with technological innovations that will transform the way we live. But these innovations offer more than just hope for a better life, but hope for better returns too. Financial returns of incredible magnitude await savvy investors and businesspeople who can see the massive changes on the horizon. This book details these fast–moving trends and innovations and offers extensive advice on how to profit from them in business and investing.
In Our Own Words
- Published on Friday, 30 May 2014 16:03
Watch Jim's presentation at the Master Investor Conference in London on 26 April 2014.
- Published on Friday, 27 September 2013 15:51
Download Jim's presentation from the Babraham Investment Forum by clicking here.
- Published on Thursday, 06 June 2013 10:48
A leader in cellular biology, Cellular Dynamics has filed for an IPO - read article here:
We discussed this company in Cracking the Code (pp 168-169), and suggested that readers keep an eye on it should it go public. It's time to take another look at this company. Their website is also a useful place when doing your research: http://www.cellulardynamics.com/.
- Published on Tuesday, 28 May 2013 11:17
Biotech is back!
- Published on Tuesday, 30 April 2013 09:42
Readers who are in the UK or planning to be in the UK should not miss a chance to attend a new science festival being held in London, Oxford and Cambridge. The festival will run from 14 to 16 May at various pubs, hence the festival has been named "Pint of Science."
Here is the link to the festival website: http://www.pintofscience.com/
- Published on Tuesday, 15 January 2013 16:47
There is a great article in The New Scientist's 14 January 2013 edition. The article makes the convincing argument that the human genome and human evolution cannot be viewed in isolation of the variety of bacteria that symbiotically co-exist in and on our bodies, referred to as our microbiome. The combined genomes (human and microbiome) have been dubbed "hologenomes".
The human body outsources essential functions to the microbiome, in the same way that a company outsources certain business processes to a third party. The company relies on the outsourced parties to thrive as a whole in the same way that humans rely on their microbiome.
This all raises new questions about the definition a - Read More
- Read More